Lotronex
Product Images NDC 54766-894
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lotronex (NDC 54766-894). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sebela Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Lot00 0006 02)
Principal Display Panel (Lotronex 0.5 mg Bottle Label)
This is a medication guide for Lotronex (alosetron hydrochloride) tablets, dispensed in a package of 30 tablets. Each film-coated tablet contains alosetron hydrochloride equivalent to 0.5 mg alosetron. The guide includes prescribing information for dosage and administration. The NDC number is 54766-894-03, and it complies with Federal law. The document is intended for healthcare professionals and patients who need information about the medication.*
Principal Display Panel (Lotronex 0.5 mg Carton)
Principal Display Panel (Lotronex 1 mg Bottle Label)
This appears to be a description of a medication called "LOTRONEX", which is a type of tablet. It contains the active ingredient alosetron hydrochloride and is available in 1mg strength. This medication is regulated by federal law and must be accompanied by a medication guide when dispensed. The text also provides contact information for the distributor, Sebela Pharmaceuticals.*
Principal Display Panel (Lotronex 1 mg Carton)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.